Credit: Shutterstock photoHIS Markit ( INFO ) saw its IBD SmartSelect Composite Rating rise to 96 Tuesday, up from 91 the day before.
[ibd-display-video id=449435 width=50 float=left autostart=true] The new rating is a sign the stock is outpacing 96% of all stocks when it comes to the most important stock-picking criteria.
HIS Markit broke out earlier, but is now trading approximately -5% below the prior 47.33 entry from a cup with handle . If a stock you're tracking clears a buy point then falls 7% or more below the original entry price, it's considered a failed base. Wait for the stock to set up and breakout from a new base and buy point.
See How IBD Helps You Make More Money In Stocks
The stock earns an 89 EPS Rating, meaning its recent quarterly and annual earnings growth tops 89% of all stocks.
Its Accumulation/Distribution Rating of B- shows moderate buying by institutional investors over the last 13 weeks.
In Q3, the company posted 27% earnings growth. That marks three straight quarters of rising EPS performance. Top line growth fell to 25%, down from 54% in the previous quarter.
HIS Markit earns the No. 3 rank among its peers in the Financial Services-Specialty industry group. CBOE ( CBOE ) is the top-ranked stock within the group.
RELATED:
Which Companies Are Now Outperforming 95% Of All Stocks?
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
